Why the study?
Does endocardial injection of erythropoietin improve myocardial function and reduce fibrosis in a pig model of chronic myocardial ischemia?
Does endocardial injection of erythropoietin improve myocardial function and reduce fibrosis in a pig model of chronic myocardial ischemia?
Endocardial EPO injection attenuates cardiac remodeling and preserves myocardial contractile reserve in a preclinical model of chronic ischemia.
No takes yet. Share an insight, caveat, or question.
Endocardial EPO attenuates remodeling in porcine chronic ischemia; hypothesis-generating and leaves open clinical translation.
Schneider et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: